CODerm Research: 303.761.0906
(option 6)
Active Clinic Trials
(1) Atopic Dermatitis (Eczema)
Eczema doesn’t have to control your life. If you are struggling with the symptoms of moderate to severe atopic dermatitis, a study involving a once daily oral pill in combination with topical corticosteroids could be an option for you.
Qualified participants include:
- Adolescents aged 12 to 17 years (minimum weight of 88 pounds)
- Those with chronic moderate to severe symptoms that started at least 3 years from planned study start date
- No prior Dupixent usage
Those that qualify will:
- Receive study-related care from a board certified physician and other medical staff at no cost
- Receive payment for each visit
(2) Atopic Dermatitis (Eczema)
Do you suffer from moderate to severe Atopic Dermatitis (Eczema)? If so, you may qualify for a clinical trial studying the effectiveness of a once daily investigational oral pill for moderate to severe atopic dermatitis.
Qualified participants include:
- Adults aged 18 and up
Those that qualify will:
- Receive study treatment from a board certified dermatologist at no cost
- Will be compensated for their time, per visit
(3) Atopic Dermatitis (Eczema)
Qualified participants:
You may qualify if you:
- Are at least 18 years of age
- Have a diagnosis of moderate to severe atopic dermatitis (AD) with an onset of symptoms at least 2 years ago
- Have tried topical steroids in the past to alleviate symptoms
Interested in participating in a clinical trial?
Please contact us at (303) 761-0906, option 6 or email us at cr@coloradodermatology.com with your name, phone number, date of birth and study of interest.
Sponsors
If you are interested in having CODerm running your study at our site please contact research@coloradodermatology.com.
